Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Human Vaccines & Immunotherapeutics
|
November 27, 2014
Awareness and understanding of cancer immunotherapy in Europe
Håkan Mellstedt, Gustav Gaudernack, Winald R Gerritsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study
Nicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Nature Reviews. Clinical Oncology
|
July 9, 2014
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study
Sanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2006
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E R O'Brien, Tudor-Eliade Ciuleanu, Hristo Tsekov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial
Rodryg Ramlau, Vera Gorbunova, Tudor Eliade Ciuleanu, et al.
Cancer
|
July 25, 2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
Sarah Danson, Mark R Middleton, Kenneth J O'Byrne, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 19, 2010
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis
Marina Chiara Garassino, Valter Torri, Giovanni Michetti, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Human Vaccines & Immunotherapeutics
|
November 27, 2014
Awareness and understanding of cancer immunotherapy in Europe
Håkan Mellstedt, Gustav Gaudernack, Winald R Gerritsen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 9, 2019
Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study
Nicholas Thatcher, Jerome H Goldschmidt, Michael Thomas, et al.
Nature Reviews. Clinical Oncology
|
July 9, 2014
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero, Gustav Gaudernack, Winald Gerritsen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2004
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study
Sanjiv S Agarwala, John M Kirkwood, Martin Gore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2006
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer
Mary E R O'Brien, Tudor-Eliade Ciuleanu, Hristo Tsekov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 12, 2012
Aflibercept and Docetaxel versus Docetaxel alone after platinum failure in patients with advanced or metastatic non-small-cell lung cancer: a randomized, controlled phase III trial
Rodryg Ramlau, Vera Gorbunova, Tudor Eliade Ciuleanu, et al.
Cancer
|
July 25, 2003
Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma
Sarah Danson, Mark R Middleton, Kenneth J O'Byrne, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 19, 2010
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis
Marina Chiara Garassino, Valter Torri, Giovanni Michetti, et al.
Page
of 4